Literature DB >> 22191719

Long-standing statin therapy and the risk of new-onset diabetes in the elderly: collateral damage caused by preventive medicine?

Luca Mascitelli1, Mark R Goldstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22191719     DOI： 10.2165/11598530-000000000-00000

Source DB:  PubMed          Journal:  Drugs Aging        ISSN： 1170-229X            Impact factor:   3.923


× No keyword cloud information.
  39 in total

Review 1.  Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus.

Authors:  P R Shepherd; B B Kahn
Journal:  N Engl J Med       Date:  1999-07-22       Impact factor: 91.245

2.  Inhibition of isoprenoid biosynthesis causes insulin resistance in 3T3-L1 adipocytes.

Authors:  L H Chamberlain
Journal:  FEBS Lett       Date:  2001-11-02       Impact factor: 4.124

3.  Why the overstated beneficial effects of statins do not resolve the cholesterol controversy.

Authors:  L Mascitelli; F Pezzetta; M R Goldstein
Journal:  QJM       Date:  2009-03-10

4.  Statins, cholesterol depletion and risk of incident diabetes.

Authors:  Luca Mascitelli; Mark R Goldstein
Journal:  Int J Cardiol       Date:  2011-09-09       Impact factor: 4.164

Review 5.  Coronary heart disease, hypercholesterolemia, and atherosclerosis. I. False premises.

Authors:  W E Stehbens
Journal:  Exp Mol Pathol       Date:  2001-04       Impact factor: 3.362

6.  30-year trends in serum lipids among United States adults: results from the National Health and Nutrition Examination Surveys II, III, and 1999-2006.

Authors:  Jerome D Cohen; Mark J Cziraky; Qian Cai; Anna Wallace; Thomas Wasser; John R Crouse; Terry A Jacobson
Journal:  Am J Cardiol       Date:  2010-08-11       Impact factor: 2.778

7.  Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis.

Authors:  David Preiss; Sreenivasa Rao Kondapally Seshasai; Paul Welsh; Sabina A Murphy; Jennifer E Ho; David D Waters; David A DeMicco; Philip Barter; Christopher P Cannon; Marc S Sabatine; Eugene Braunwald; John J P Kastelein; James A de Lemos; Michael A Blazing; Terje R Pedersen; Matti J Tikkanen; Naveed Sattar; Kausik K Ray
Journal:  JAMA       Date:  2011-06-22       Impact factor: 56.272

8.  Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial.

Authors:  Anthony Keech; David Colquhoun; James Best; Adrienne Kirby; R John Simes; David Hunt; Wendy Hague; Elaine Beller; Manjula Arulchelvam; Jennifer Baker; Andrew Tonkin
Journal:  Diabetes Care       Date:  2003-10       Impact factor: 19.112

9.  Differential metabolic effects of pravastatin and simvastatin in hypercholesterolemic patients.

Authors:  Kwang Kon Koh; Michael J Quon; Seung Hwan Han; Yonghee Lee; Soo Jin Kim; Jeong Beom Park; Eak Kyun Shin
Journal:  Atherosclerosis       Date:  2008-09-27       Impact factor: 5.162

Review 10.  National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants.

Authors:  Goodarz Danaei; Mariel M Finucane; Yuan Lu; Gitanjali M Singh; Melanie J Cowan; Christopher J Paciorek; John K Lin; Farshad Farzadfar; Young-Ho Khang; Gretchen A Stevens; Mayuree Rao; Mohammed K Ali; Leanne M Riley; Carolyn A Robinson; Majid Ezzati
Journal:  Lancet       Date:  2011-06-24       Impact factor: 79.321
View more
  1 in total

Review 1.  Do statins cause diabetes?

Authors:  Mark R Goldstein; Luca Mascitelli
Journal:  Curr Diab Rep       Date:  2013-06       Impact factor: 4.810
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.